Proteomic analysis of carbonylated proteins in the monkey substantia nigra after ischemia-reperfusion

References

• Chen X, Wu G, Schwarzschild MA. Urate in Parkinson's disease: more than a biomarker?Curr Neurol Neurosci Rep 2012;12:367–375.
   PubMed Web of Science ®Google Scholar
• Miller RL, James-Kracke M, Sun GY, Sun AY. Oxidative and inflammatory pathways in Parkinson's disease. Neurochem Res 2009;34:55–65.
   PubMed Web of Science ®Google Scholar
• Collier TJ, Kanaan NM, Kordower JH. Ageing as a primary risk factor for Parkinson's disease: evidence from studies of non-human primates. Nature reviews. Neuroscience 2011; 12:359–366.
   PubMed Web of Science ®Google Scholar
• Mariani E, Polidori MC, Cherubini A, Mecocci P. Oxidative stress in brain aging, neurodegenerative and vascular diseases: an overview. J Chromatogr B Analyt Technol Biomed Life Scie 2005;827:65–75.
   PubMed Web of Science ®Google Scholar
• Coyle JT, Puttfarcken P. Oxidative stress, glutamate, and neurodegenerative disorders. Science 1993;262:689–695.
   PubMed Web of Science ®Google Scholar
• Nakabeppu Y, Tsuchimoto D, Furuichi M, Sakumi K. The defense mechanisms in mammalian cells against oxidative damage in nucleic acids and their involvement in the suppression of mutagenesis and cell death. Free Radical Res 2004;38:423–429.
   PubMed Web of Science ®Google Scholar
• Andersen JK. Oxidative stress in neurodegeneration: cause or consequence?Nat Med 2004;10:S18–S25.
   PubMed Web of Science ®Google Scholar
• Avery SV. Molecular targets of oxidative stress. Biochem J 2011;434:201–210.
   PubMed Web of Science ®Google Scholar
• Maisonneuve E, Ducret A, Khoueiry P, Lignon S, Longhi S, Talla E, Dukan S. Rules governing selective protein carbonylation. PloS One 2009;4:e7269.
   PubMed Web of Science ®Google Scholar
• Alam ZI, Daniel SE, Lees AJ, Marsden DC, Jenner P, Halliwell B. A generalised increase in protein carbonyls in the brain in Parkinson's but not incidental Lewy body disease. J Neurochem 1997;69:1326–1329.
   PubMed Web of Science ®Google Scholar
• Yamashima T, Kohda Y, Tsuchiya K, Ueno T, Yamashita J, Yoshioka T, Kominami E. Inhibition of ischaemic hippocampal neuronal death in primates with cathepsin B inhibitor CA-074: a novel strategy for neuroprotection based on ‘calpain-cathepsin hypothesis’. Eur J Neurosci 1998;10: 1723–1733.
   PubMed Web of Science ®Google Scholar
• Yamashima T, Saido TC, Takita M, Miyazawa A, Yamano J, Miyakawa A, et al. Transient brain ischaemia provokes Ca2+, PIP2 and calpain responses prior to delayed neuronal death in monkeys. Eur J Neurosci 1996;8:1932–1944.
   PubMed Web of Science ®Google Scholar
• Lehtinen MK, Bonni A. Modeling oxidative stress in the central nervous system. Curr Mol Med 2006;6:871–881.
   PubMed Web of Science ®Google Scholar
• Oikawa S, Yamada T, Minohata T, Kobayashi H, Furukawa A, Tada-Oikawa S, et al. Proteomic identification of carbonylated proteins in the monkey hippocampus after ischemia-reperfusion. Free Radic Biol Med 2009;46: 1472–1477.
   PubMed Web of Science ®Google Scholar
• Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976;72:248–254.
   PubMed Web of Science ®Google Scholar
• Nakamura A, Goto S. Analysis of protein carbonyls with 2,4-dinitrophenyl hydrazine and its antibodies by immunoblot in two-dimensional gel electrophoresis. J Biochem 1996; 119:768–774.
   PubMed Web of Science ®Google Scholar
• Kondo T, Hirohashi S. Application of highly sensitive fluorescent dyes (CyDye DIGE Fluor saturation dyes) to laser microdissection and two-dimensional difference gel electrophoresis (2D-DIGE) for cancer proteomics. Nat Protoc 2006;1: 2940–2956.
   PubMed Web of Science ®Google Scholar
• Aksenov MY, Aksenova MV, Butterfield DA, Geddes JW, Markesbery WR. Protein oxidation in the brain in Alzheimer's disease. Neuroscience 2001;103:373–383.
   PubMed Web of Science ®Google Scholar
• Yata K, Matchett GA, Tsubokawa T, Tang J, Kanamaru K, Zhang JH. Granulocyte-colony stimulating factor inhibits apoptotic neuron loss after neonatal hypoxia-ischemia in rats. Brain Res 2007;1145:227–238.
   PubMed Web of Science ®Google Scholar
• Butterfield DA, Perluigi M, Sultana R. Oxidative stress in Alzheimer's disease brain: new insights from redox proteomics. Eur J Pharmacol 2006;545:39–50.
   PubMed Web of Science ®Google Scholar
• Mirzaei H, Regnier F. Affinity chromatographic selection of carbonylated proteins followed by identification of oxidation sites using tandem mass spectrometry. Anal Chem 2005; 77:2386–2392.
   PubMed Web of Science ®Google Scholar
• Wilmarth PA, Tanner S, Dasari S, Nagalla SR, Riviere MA, Bafna V, et al. Age-related changes in human crystallins determined from comparative analysis of post-translational modifications in young and aged lens: does deamidation contribute to crystallin insolubility?J Proteome Res 2006;5:2554–2566.
   PubMed Web of Science ®Google Scholar
• Basso M, Giraudo S, Corpillo D, Bergamasco B, Lopiano L, Fasano M. Proteome analysis of human substantia nigra in Parkinson's disease. Proteomics 2004;4:3943–3952.
   PubMed Web of Science ®Google Scholar
• Diedrich M, Mao L, Bernreuther C, Zabel C, Nebrich G, Kleene R, Klose J. Proteome analysis of ventral midbrain in MPTP-treated normal and L1cam transgenic mice. Proteomics 2008;8:1266–1275.
   PubMed Web of Science ®Google Scholar
• Jin J, Meredith GE, Chen L, Zhou Y, Xu J, Shie FS, et al. Quantitative proteomic analysis of mitochondrial proteins: relevance to Lewy body formation and Parkinson's disease. Brain Res Mol Brain Res 2005;134:119–138.
   PubMedGoogle Scholar
• Periquet M, Corti O, Jacquier S, Brice A. Proteomic analysis of parkin knockout mice: alterations in energy metabolism, protein handling and synaptic function. J Neurochem 2005;95:1259–1276.
   PubMed Web of Science ®Google Scholar
• Cantu D, Schaack J, Patel M. Oxidative inactivation of mitochondrial aconitase results in iron and H2O2-mediated neurotoxicity in rat primary mesencephalic cultures. PloS One 2009;4:e7095.
   PubMed Web of Science ®Google Scholar
• Drechsel DA, Patel M. Role of reactive oxygen species in the neurotoxicity of environmental agents implicated in Parkinson's disease. Free Radic Biol Med 2008;44:1873–1886.
   PubMed Web of Science ®Google Scholar
• Gille G, Reichmann H. Iron-dependent functions of mitochondria–relation to neurodegeneration. J Neural Transm 2011;118:349–359.
   PubMed Web of Science ®Google Scholar
• Patel M. Mitochondrial dysfunction and oxidative stress: cause and consequence of epileptic seizures. Free Radic Biol Med 2004;37:1951–1962.
   PubMed Web of Science ®Google Scholar
• Butterfield DA. Proteomics: a new approach to investigate oxidative stress in Alzheimer's disease brain. Brain Res 2004; 1000:1–7.
   PubMed Web of Science ®Google Scholar
• Choi J, Forster MJ, McDonald SR, Weintraub ST, Carroll CA, Gracy RW. Proteomic identification of specific oxidized proteins in ApoE-knockout mice: relevance to Alzheimer's disease. Free Radic Biol Med 2004;36:1155–1162.
   PubMed Web of Science ®Google Scholar
• Castegna A, Aksenov M, Thongboonkerd V, Klein JB, Pierce WM, Booze R, et al. Proteomic identification of oxidatively modified proteins in Alzheimer's disease brain. Part II: dihydropyrimidinase-related protein 2, alpha-enolase and heat shock cognate 71. J Neurochem 2002;82:1524–1532.
   PubMed Web of Science ®Google Scholar
• Coleman PD, Flood DG. Neuron numbers and dendritic extent in normal aging and Alzheimer's disease. Neurobiol Aging 1987;8:521–545.
   PubMed Web of Science ®Google Scholar
• Gomez-Puertas P, Martin-Benito J, Carrascosa JL, Willison KR, Valpuesta JM. The substrate recognition mechanisms in chaperonins. J Mol Recognit 2004;17:85–94.
   PubMed Web of Science ®Google Scholar
• Liu X, Lin CY, Lei M, Yan S, Zhou T, Erikson RL. CCT chaperonin complex is required for the biogenesis of functional Plk1. Mol Cell Biol 2005;25:4993–5010.
   PubMed Web of Science ®Google Scholar
• Schuller E, Gulesserian T, Seidl R, Cairns N, Lube G. Brain t-complex polypeptide 1 (TCP- 1) related to its natural substrate beta1 tubulin is decreased in Alzheimer's disease. Life Sci 2001;69:263–270.
   PubMed Web of Science ®Google Scholar
• Yoo BC, Vlkolinsky R, Engidawork E, Cairns N, Fountoulakis M, Lubec G. Differential expression of molecular chaperones in brain of patients with Down syndrome. Electrophoresis 2001;22:1233–1241.
   PubMed Web of Science ®Google Scholar
• Kodavanti PR, Osorio C, Royland JE, Ramabhadran R, Alzate O. Aroclor 1254, a developmental neurotoxicant, alters energy metabolism- and intracellular signaling-associated protein networks in rat cerebellum and hippocampus. Toxicol Appl Pharmacol 2011;256:290–299.
   PubMed Web of Science ®Google Scholar
• Sullivan PG, Brown MR. Mitochondrial aging and dysfunction in Alzheimer's disease. Prog Neuropsychopharmacol Biol Psychiatry 2005;29:407–410.
   PubMed Web of Science ®Google Scholar
• Korotchkina LG, Yang H, Tirosh O, Packer L, Patel MS. Protection by thiols of the mitochondrial complexes from 4-hydroxy-2-nonenal. Free Radic Biol Med 2001;30:992–999.
   PubMed Web of Science ®Google Scholar
• Frigerio F, Casimir M, Carobbio S, Maechler P. Tissue specificity of mitochondrial glutamate pathways and the control of metabolic homeostasis. Biochim Biophys Acta 2008; 1777:965–972.
   PubMed Web of Science ®Google Scholar
• Lai X, Wang J, Nabar NR, Pan S, Tang C, Huang Y, et al. Proteomic response to acupuncture treatment in spontaneously hypertensive rats. PloS One 2012;7:e44216.
   PubMed Web of Science ®Google Scholar
• Michaelis EK, Wang X, Pal R, Bao X, Hascup KN, Wang Y, et al. Neuronal Glud1 (glutamate dehydrogenase 1) over- expressing mice: increased glutamate formation and synaptic release, loss of synaptic activity, and adaptive changes in genomic expression. Neurochem Int 2011;59:473–481.
   PubMed Web of Science ®Google Scholar
• Opii WO, Joshi G, Head E, Milgram NW, Muggenburg BA, Klein JB, et al. Proteomic identification of brain proteins in the canine model of human aging following a long-term treatment with antioxidants and a program of behavioral enrichment: relevance to Alzheimer's disease. Neurobiol Aging 2008;29:51–70.
   PubMed Web of Science ®Google Scholar
• Buono P, D’Armiento FP, Terzi G, Alfieri A, Salvatore F. Differential distribution of aldolase A and C in the human central nervous system. J Neurocytol 2001;30:957–965.
   PubMedGoogle Scholar
• McKenna MC, Hopkins IB, Lindauer SL, Bamford P. Aspartate aminotransferase in synaptic and nonsynaptic mitochondria: differential effect of compounds that influence transient hetero-enzyme complex (metabolon) formation. Neurochem Int 2006;48:629–636.
   PubMed Web of Science ®Google Scholar
• Chang TC, Hsiao CD, Wu SJ, Wang C. The effect of mutating arginine-469 on the substrate binding and refolding activities of 70-kDa heat shock cognate protein. Arch Biochem Biophys 2001;386:30–36.
   PubMed Web of Science ®Google Scholar
• Sahara S, Yamashima T. Calpain-mediated Hsp70.1 cleavage in hippocampal CA1 neuronal death. Biochem Biophys Res Commun 2010;393:806–811.
   PubMed Web of Science ®Google Scholar
• Beere HM, Wolf BB, Cain K, Mosser DD, Mahboubi A, Kuwana T, et al. Heat-shock protein 70 inhibits apoptosis by preventing recruitment of procaspase-9 to the Apaf-1 apoptosome. Nat Cell Biol 2000;2:469–475.
   PubMed Web of Science ®Google Scholar
• Saleh A, Srinivasula SM, Balkir L, Robbins PD, Alnemri ES. Negative regulation of the Apaf-1 apoptosome by Hsp70. Nat Cell Biol 2000;2:476–483.
   PubMed Web of Science ®Google Scholar
• Kirkegaard T, Roth AG, Petersen NH, Mahalka AK, Olsen OD, Moilanen I, et al. Hsp70 stabilizes lysosomes and reverts Niemann-Pick disease-associated lysosomal pathology. Nature 2010;463:549–553.
   PubMed Web of Science ®Google Scholar
• Nylandsted J, Gyrd-Hansen M, Danielewicz A, Fehrenbacher N, Lademann U, Hoyer-Hansen M, et al. Heat shock protein 70 promotes cell survival by inhibiting lysosomal membrane permeabilization. J Exp Med 2004;200:425–435.
   PubMed Web of Science ®Google Scholar
• Zhu H, Yoshimoto T, Imajo-Ohmi S, Dazortsava M, Mathivanan A, Yamashima T. Why are hippocampal CA1 neurons vulnerable but motor cortex neurons resistant to transient ischemia?J Neurochem 2012;120:574–585.
   PubMed Web of Science ®Google Scholar
• Yamashima T. Hsp70.1 and related lysosomal factors for necrotic neuronal death. J Neurochem 2012;120:477–494.
   PubMed Web of Science ®Google Scholar
• Yamashima T, Oikawa S. The role of lysosomal rupture in neuronal death. Prog Neurobiol 2009;89:343–358.
   PubMed Web of Science ®Google Scholar